immatics biotechnologies is based in Tuebingen, Germany. It has raised $312M in total funding. Latest round: Other Equity.
immatics biotechnologies is based in Tuebingen, Germany. immatics biotechnologies has raised $312M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an Other Equity announced in August 2019. The round record for immatics biotechnologies runs through 2019; nothing later has been disclosed. Investors on record include Celgene, Wellington Partners, Amgen Ventures, AT Impf, Dievini Hopp Biotech Holding, MIG Capital and 1 others. 7 distinct backers are named across the disclosed rounds.
immatics biotechnologies totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Tuebingen below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026